Related Experiment Video
Updated: Feb 3, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Clinical and Morphological Aspects in Assessing the Safety of OSPL-502 with Repeated Dose Administration
Sergey A Zhuchkov1, Alexandr S Kinzirsky2, Irina V Koroleva2
1Department of Histology, Cytology, and Embryology, Orel State University, Orel, Russia.
Background:
OSPL-502 is a new potential medicinal drug which stimulates a cognitive function. It is necessary to reveal clinical manifestations of its general toxic effect and determine organs that are most heavily affected by this pharmacological substance.
Aims:
To describe and estimate clinical and histopathological changes in the organism of experimental animals in response to the repeated administration of pharmacological substance OSPL-502.
Material And Methods:
The study was conducted by the OECD Guidelines (Test No. 407) on Sprague-Dawley rats. The drug was administered at the dose of 20, 60 and 180 mg/kg.
Results:
The repeated doses of OSPL-502 have not caused any toxic effects on the growth of body weight, food and water consumption of the tested animals, or affected the musculoskeletal system and exploratory behaviour of the rats in the doses of 20 and 60 mg/kg. The dose of 180 mg/kg (1800 times larger than the therapeutic dose) has shown clinical signs of toxicity in females but has not resulted in the death of the animals. Due to morphological methods, we have found histostructural changes in the liver, kidneys and adrenal glands of the rats that were treated with the test substance in the maximum dose. These changes are reversible and reduce within 14 days after the admission of the studied substances is cancelled.
Conclusion:
OSPL-502 at the dose of 180 mg/kg has a weakly pronounced toxic effect, the dose of 60 mg/kg is the threshold, and that of 20 mg/kg is no-observable-adverse-effect-level (NOAEL); the liver, kidneys and adrenal glands can be considered target-organs for the tested substance.
Insights
OSPL-502, a cognitive stimulant, showed minimal toxicity in rats. High doses affected the liver, kidneys, and adrenal glands, but these changes were reversible, indicating a favorable safety profile.
Area of Science:
- Pharmacology
- Toxicology
- Drug Safety Evaluation
Background:
- OSPL-502 is a novel drug candidate designed to enhance cognitive function.
- Assessing the general toxic effects and identifying target organs of OSPL-502 is crucial for its clinical development.
Purpose of the Study:
- To evaluate the clinical and histopathological changes induced by repeated administration of OSPL-502 in experimental animals.
- To determine the dose-dependent toxicity and identify potential target organs of OSPL-502.
Main Methods:
- The study followed OECD Guidelines (Test No. 407) using Sprague-Dawley rats.
- OSPL-502 was administered at doses of 20, 60, and 180 mg/kg.
- Clinical observations, body weight, food/water consumption, and histopathological examinations were conducted.
Main Results:
- No adverse effects on body weight, consumption, musculoskeletal system, or exploratory behavior were observed at 20 and 60 mg/kg.
- The 180 mg/kg dose exhibited mild clinical toxicity signs in female rats, without mortality.
- Histostructural changes were noted in the liver, kidneys, and adrenal glands at the highest dose, which were reversible within 14 days post-treatment.
Conclusions:
- OSPL-502 demonstrates a weakly pronounced toxic effect at 180 mg/kg, with 60 mg/kg as the threshold dose and 20 mg/kg as the no-observable-adverse-effect-level (NOAEL).
- The liver, kidneys, and adrenal glands are identified as target organs for OSPL-502 toxicity.
- The observed histopathological changes are reversible, suggesting a favorable safety profile for OSPL-502.
Related Concept Videos
Survey Safety
Angina III: Clinical Manifestations and Assessment
Dose Size and Dosing Frequency: Determination Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Household Wiring And Electrical Safety
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...

